Connect with us

Cannabis News

If the FDA is Incapable of Providing Guidance on CBD, Why Do We Even Have an FDA at All?



fda on cbd regs

The FDA, or the Food and Drug Administration, has long been touted as the guardian of public health, responsible for regulating everything from the drugs we take to the food we eat. But the reality is far from what it seems. Time and time again, the FDA has shown itself to be an inept and unreliable organization, one that is more concerned with serving the interests of Big Pharma than the well-being of the American people.


Let’s take a walk down memory lane, shall we? The FDA approved Thalidomide, a morning sickness drug that caused birth defects, in the 1950s and 60s. The disaster was only discovered after it was too late, causing widespread harm to countless families. Fast forward to the 90s, the FDA approved Vioxx, a painkiller that was later found to cause heart attacks and strokes. These are just two examples of the many times the FDA has dropped the ball, putting profits before people.


But it’s not just a matter of historical failures. The FDA’s track record in recent years is just as concerning. They’ve been slow to approve safe and effective drugs like medical marijuana, while fast-tracking dangerous and ineffective drugs like OxyContin. The opioid epidemic that has ravaged America in recent years is largely the result of the FDA’s incompetence and indifference.


In the words of Robert Anton Wilson, “the universe is a cosmic joke played on us by a universal sense of humor.” And the FDA is no exception. Its inability to effectively regulate the products that we put into our bodies is a testament to the absurdity of our world.


In conclusion, the FDA’s history of approving dangerous drugs, blocking safe and effective treatments, and prioritizing profits over people, is a clear indication of their ineptitude.


One of their recent failures comes in the form of “passing the buck” to Congress in relation to providing clear regulations on CBD.


What this means is that for now, everything will remain “as is” and now Congress will have to begin deliberation on what the type of regulation would be. But isn’t it the job of the FDA to provide those regulations?


If this is all sounding odd to you, don’t worry – it is!


The FDA has long been a critical part on maintaining the War on Drugs by playing the “Catch-22 of the DEA and the FDA”. In other words, when someone in the public asks the DEA to reschedule any drug in Schedule I, they would say that first they would need a report from the FDA.


Going to the FDA, the will tell you – certainly! We just need some permissions from the DEA. So you’re back at the DEA and say, “So the FDA told me I need something from you so they can give me access…and the DEA says, “Not a problem! We just need a few studies from the FDA in order to give you those permissions…”


And then you realize that the War on Drugs was a corporate power play that essentially monopolized all drug manufacturing and distribution in the hands of a few mega corps.




The point is, that the whole system is created so that it’s insanely difficult to legalize any drug that would cut into the profit margins of Big Pharma, and those who dare to even attempt this will be met with Blackhawk helicopters and paramilitary units.



According to MJBizDaily, the reason why the FDA doesn’t want to touch CBD is because it’s linked to the 2018 Farm Bill, that legalized Hemp. They argue that Congress would have to renegotiate that bill in order for them to be able to do any regulatory oversight.


And to be fair, they aren’t wrong either. The FDA can’t change laws, only Congress can. The 2018 Farm Bill made things like Delta-8 legal as long as its derived from Hemp.


Therefore, even if the FDA says anything about it, they won’t be able to do anything about it.


Here’s a snippet from the MJBizDaily Article


A massive piece of legislation that covers farm subsidies, food-stamp benefits and many other topics, the 2018 Farm Bill – promoted by then-Senate Majority Leader Mitch McConnell and signed into law by former President Donald Trump –  legalized hemp production nationwide.


In so doing, it also predicated the CBD boom and, along with it, the rise of novel intoxicating cannabinoids derived from hemp.


Since that time, the FDA has been on notice to figure out how to regulate an onslaught of products containing CBD and other cannabinoids derived from hemp.

Rather than do that, the FDA declined Thursday to regulate CBD products including other food supplements, saying its existing regulatory frameworks were inadequate – and that Congress should tell the FDA what to do.


In a statement Thursday, Dr. Janet Woodcock, the FDA’s principal deputy commissioner, said the agency “has concluded that a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks.”

“The use of CBD raises various safety concerns, especially with long-term use,” Woodcock added.

“The agency is prepared to work with Congress on this matter.”

Though Woodcock did not mention other cannabinoids that have gained popularity over the past four years – including delta-8 and delta-10 THC, which can be derived from CBD via a chemical process, as well as delta-9 THC – the FDA has noted the “serious health risks” posed by so-called alternative cannabinoids and has been tracking reports of adverse health effects.


 In other words, it took them 4-years to say that they don’t have the tools or parameters to do the work needed. 4 YEARS!!!!


Yet, along roles a “pandemic” with a virus of 99.6% survivability and they can approve booster after booster in a matter of months…


I wonder why they can approve Pharma’s drugs in a matter of months but are incapable of telling Congress “they can’t regulate CBD” for 4-years!



The idea that marijuana could reduce Big Pharma’s revenues is an age-old one, and it is a classic example of the little guy defeating the big bully. It’s a tale that has often been told in the pages of American history, and it’s an one that is currently being written in the world of medical treatment.


The people at Big Pharma have been making a killing for years by marketing various medicines and potions that claim to be able to treat all of your ailments. But now that this wild card, this rebel force, this green threat has entered the picture, their earnings are suddenly in peril.



Cannabis is a potent medication that has been used for treating a variety of diseases for thousands of years. It is a natural treatment that has repeatedly been shown to be successful in treating a variety of diseases, including pain, anxiety, and depression. Furthermore, it is a treatment that is easily accessible to everyone who seeks it.


How does this affect Big Pharma’s bottom line, then? Simple. Big Pharma’s profits decline if people use cannabis instead of their proprietary medications. And that bothers them a great deal.


Big Pharma, you see, is a complicated web of interests with ties to both the highest echelons of government and the shadowy underbelly of the economy. It is not just some faceless corporation. It’s a huge conspiracy, one that’s out to crush the underdog and preserve a tight grip on the market.


But things are changing. People are becoming more aware of the advantages of cannabis and are demanding access to it. And even the largest firms are forced to pay attention when the public demands something.


However, these businesses continue to hold a majority of the market thanks to strategies and practices like “passing the buck” by the FDA.


The truth is that every time cannabis is legalized, Pharma loses billions. Millions of individuals could benefit from CBD, which is a truly wonderful material. However, because it is currently in a legal “limbo,” it cannot be widely dispersed, and investors are wary of making purchases on the assumption that “what if the government decides it’s bad again?”


This is also the main justification for why marijuana is still illegal in the US.


My friends, it’s time for the populace to advance past the government. We have been held hostage by a system that has been bought and paid for by the very industries it is meant to control for far too long. The government has evolved into a tool of the oppressors, used to keep the populace under control and in line.


Consider Big Pharma as an example. They have dirty hands in every pie, and they purchase politicians’ and regulators’ support with their influence and power. What do they get in return for this? a carte blanche to act however they choose, to push their medications and therapies on a gullible populace, and to extort them for everything they’re worth.


What about the FDA, then? The very organization tasked with keeping us secure has failed miserably. They are so deeply entwined with Big Pharma that they are unable to control the regulation of something as basic and natural as CBD. They have refused to acknowledge this remarkable plant and have chosen to ignore the numerous studies that demonstrate its advantages.


Folks, this is the current status of our government. We are dealing with a dysfunctional system here. It’s time for us to move past it, to liberate ourselves from its bonds, and to take charge of our own lives.


I’d say Robert Anton Wilson is one of my heroes. He had a unique perspective on the world and was a true rebel. He was aware that reality is dynamic and that our perceptions and beliefs may influence it. He also showed us that the only way to change the world is to alter our perspective on it.


Therefore, that is what we must do. We need to abandon the outdated paradigms and adopt a fresh perspective that is built on liberty, autonomy, and self-determination. In order to create a new route that is driven by our own ambitions and objectives, we must reject the conventional methods of doing things.


My friends, it’s time for us to progress past government. It’s time for us to reclaim our freedom and our power. Because we can only change ourselves if we change the world. So let’s take action, unleash the potential of our hearts and brains, and build a new reality free from the constraints of big business and the tyranny of the state.





Source link

Continue Reading

Cannabis News

Does Cannabis Cure Postpartum Depression? One Mom Swears It Did the Trick for Her!




cannabis for postpartum depression

Early pregnancy is rife with postpartum depression and other mood problems. We realize it’s an overstatement, but those first few days, weeks, and months are HARD. Sleep deprivation, aching, leaking, or engorged breasts… throw in mental health difficulties, and you have a recipe for total exhaustion.


Fortunately, there is less stigma associated with postpartum depression (PPD) than formerly. PPD is being discussed more frequently, and there is a better awareness of new parents’ symptoms and many remedies. Many moms are finding success with prioritizing rest, exercise, Vitamin D, and even using CBD to assist control anxiety when diagnosed and addressed early.

The Rise of CBD as a Postpartum Mood Disorder Remedy

Over the past few years, CBD has gained remarkable popularity as a remedy for addressing symptoms linked to postpartum mood disorders, such as anxiety, irritability, and insomnia. Additionally, it has shown promise in supporting the physical recovery process following childbirth.


Georgeana Ortiz, the founder of the CBD company Cerena, emphasizes, “CBD serves as an excellent gateway, beckoning you to step away from the turmoil within your mind and transition into a composed and collected state of being. Ultimately, CBD is a pivotal component in facilitating your journey to move beyond self-imposed barriers and return to a state of thriving rather than merely surviving.”


While both THC and CBD are cannabinoids, CBD has no hallucinogenic effects. In other words, it won’t get you high. When selecting a CBD product, search for a high-quality, full-spectrum oil tailored to your needs or symptoms. Cerena, for example, makes a full-spectrum, certified organic CBD oil called “Calma” that’s expressly intended to relieve stress and anxiety.


Natasha’s Journey: From Postpartum Depression to CBD Advocate

In a noteworthy case, a woman claims to have treated her postpartum depression using cannabis oil. Natasha Doran, 33, began dealing with her mental health issues after giving birth to her son, Isaac, now four, in May 2019.


Despite attempting therapy and medication, she experienced “no improvement” in her severe daily panic attacks. After contacting her general practitioner, engaging in online therapy, and commencing antidepressant treatment, she felt “worse than ever.”


By June 2020, her ability to leave the house had deteriorated, and she was grappling with debilitating insomnia. At the suggestion of a friend, Natasha decided to give CBD oil a chance and made her initial online purchase of a 10ml bottle for £60.


Cannabidiol, a chemical compound in cannabis with purported medical benefits, became her solution. She started by taking a daily drop under her tongue, and soon, she noted a significant alleviation of her anxiety and depression symptoms.


Just six months after incorporating CBD into her routine, Natasha found herself back at the gym, enjoying restful nights and free from panic attacks. She was so impressed by the positive impact of the hemp product that she decided to start her own company, which she named Hemp-Aid Limited, in November 2022, leading her to leave her previous role at a nursery.


In Moreton on the Wirral, Natasha reflected, “She couldn’t sleep, and leaving the house was daunting. There were moments when she felt utterly hopeless. Initially skeptical, she conducted thorough research on CBD before giving it a try, despite initial reservations from her family.”


“After several months of incorporating CBD into her daily routine, she felt a renewed sense of purpose. She eagerly reconnected with friends, resumed gym visits, and arranged playdates for her son. In essence, CBD gave her life back.”


Despite a smooth pregnancy, Natasha had a “traumatic” childbirth experience with her first son at Whiston Hospital in Prescot, Lancashire. Isaac was born with the umbilical cord wrapped around his neck, and the resulting C-section led to severe pain due to blood clots. Reflecting on this period, Natasha, a former nursery manager, confessed that she lost herself after the birth.


She reflected that the surgery left her in considerable pain, which wasn’t the most auspicious start to her journey into motherhood. Following a hospital stay that lasted a week, Natasha soon found herself in profound depression after returning home with her newborn.


In her own words, Natasha explained that she initially thought her feelings were typical for a new mother. However, when she lost all motivation to venture outside, she recognized something was amiss. She felt compelled to act when concerned about her son Isaac’s social development due to her isolation.


After enduring four years of disappointment with traditional treatments, she confided in her partner, who suggested experimenting with CBD oil. Describing her experience, Natasha recounted that the impact was immediate.

She felt an incredible sense of relaxation and tranquility. She regained control over her heart rate and thought patterns, which was one of the best periods of sleep she had experienced in a long time.

She abstained from alcohol, which significantly contributed to her relief from depression. She now enjoys a profound sense of health and fitness. “I’ve never been this committed to a healthy lifestyle. After several months of incorporating CBD into her daily routine, she extensively researched improving her overall well-being.”


She continues incorporating CBD oil into her daily regimen and has taken it further by establishing her own company, Hemp Aid Limited. Natasha expressed her motivation, saying, “The health benefits are remarkable. CBD cured her post-natal depression when she felt utterly hopeless, and now she aspires to provide the same relief to others.


According to the NHS website, “some products claiming to be medical cannabis, such as CBD oil or hemp oil, are legally available to buy as food supplements from health stores.” However, there is no guarantee that products are of high quality or give any health benefits.”


“There is insufficient scientific evidence to support the claim that CBD is an effective treatment for depression or anxiety,” according to the Anxiety and Depression Association of America. That isn’t to say it wouldn’t help, but there haven’t been enough well-controlled clinical research to support CBD as a treatment for anxiety or depression.Much more research is needed to assess CBD as a potential therapy for anxiety and depression.”


While CBD has shown promise in addressing various health issues, including postpartum depression, it is important to approach its use cautiously. The quality and effectiveness of CBD products can vary, and there is still a need for more comprehensive scientific research and clinical trials to establish its efficacy as a treatment for these conditions. Individuals considering CBD for mental health concerns should consult with healthcare professionals and make informed decisions regarding its use.





Source link

Continue Reading

Cannabis News

Can You Mix Two Different Cannabis Strains Together and Smoke It? What Happens to Your High?




combining cannabis strains

While you’ve likely experienced smoking from a pipe or bowl with traces of a different weed strain, combining two strains isn’t typically the first choice for most people. The question is, can you deliberately craft distinct highs by combining different cannabis strains and experimenting like a scientist? Some individuals believe it’s possible, while others remain skeptical.


Blending different strains can enhance the renowned entourage effect of cannabis. This effect occurs when various components of cannabis synergize to create a potent high, surpassing the effects of consuming a single cannabinoid in isolation. The entourage effect leads many to argue that using just one cannabinoid for relaxation or therapeutic? What happens when you combine two cannabis strains isn’t as effective as consuming the entire plant, including its terpenes.


If you’re pursuing truly unique effects, mixing two strains can deliver just that, for better or worse. Nevertheless, it’s worth noting that combining strains isn’t overly complex. While the outcome might range from a powerful high to one that tucks you in for the night, especially when you’ve acquired high-quality cannabis, there’s generally no reason to anticipate adverse consequences.

The Entourage Effect

While further research is essential, the existing knowledge suggests that when you blend specific cannabinoids and terpenes tailored to your body’s needs, it can result in a synergistic phenomenon known as the Entourage Effect. This effect can offer a more complete cannabis experience compared to consuming isolated cannabinoids such as THC or CBD.

This phenomenon is rooted in the fact that each of us possesses our internal endocannabinoid system (ECS), with the prefix “endo” indicating its presence within the body.


By blending two or more varieties of cannabis, you expand your body’s and endocannabinoid system’s exposure to a broader array of cannabinoids and terpenes. In doing so, you potentially unlock the health benefits associated with these additional compounds.

The advantages of mixing strains extend beyond simply enhancing potential medicinal benefits. Even recreational users can employ the concept of strain mixing to regulate the potency and effects of their cannabis consumption.


As an example, suppose a potent strain yields unwanted effects when consumed. Blending it with a strain featuring lower THC levels and elevated cannabidiol (CBD) content can alleviate some of these undesirable outcomes. CBD achieves this by diminishing THC’s tendency to bind strongly to cannabinoid receptors within our endocannabinoid system (ECS), thereby assisting in reducing any adverse consequences that might arise from high-THC cannabis.


This is just one example of how the interplay between cannabinoids and terpenes with our ECS significantly influences the potency and effects of various cannabis strains. Consequently, this variation is why two individuals consuming the same strain may encounter distinctly divergent effects.

Mixing Strains of Weed

To create a mix of weed strains, often called a “weed salad,” the simplest approach is to grind your cannabis flowers and combine the two chosen strains. From there, various options open, including smoking, vaping, or crafting your cannabutter.


Now, let’s explore the more intricate aspect: determining the ideal blend for your needs. Should you combine an Indica with a Sativa? Is it acceptable to mix two Indicas or two Sativas? If you decide to mix Sativa and Indica strains, how should you balance the proportions of each? Can you blend older cannabis with fresher batches? What about combining high-THC cannabis with low-THC cannabis or CBD strains?


Given the many variables involved, here are some tips to note when mixing different cannabis strains;

Tip 1: Mix Weed with Similar Scents

You’re likely aware that the distinctive aroma of each cannabis strain is attributed to its terpenes. Additionally, you recognize that the fragrance of a cannabis flower can play a pivotal role in gauging whether its effects align with your body and endocannabinoid system. If a strain’s aroma doesn’t resonate with you, it might indicate that it’s not a suitable match for your system, and your overall experience may be less enjoyable.


Therefore, our initial advice is to combine strains with comparable, pleasant scents or scents that you believe would harmonize well. Conversely, a strain with an appealing aroma could indicate that it will likely complement your system.


If you are uncertain, you can begin by grinding and blending a small quantity. Afterward, taste it and decide if you wish to proceed with mixing a larger batch.

Tip 2: Mix Complement Flavours

For instance, consider combining a strain with a tea-like flavor with another boasting a lemon haze profile. This combination could deliver a refreshing and enjoyable session.

Alternatively, if you have a penchant for cheese strains, you might experiment by mixing cheesecake with strawberry cookies OG for a unique taste experience.


Keep in mind that the ideal cannabis blend varies from person to person. What provides an exceptional experience for you might be less enjoyable for someone else. Therefore, don’t hesitate to let your creativity run wild and concoct various strains with flavors that pique your interest. We recommend starting with a small blend to ensure it aligns with your preferences before proceeding with a larger mix.


Tip 3: Mix Strains With Similar Effects

This tip may well be the most important of all. A practical approach to blending cannabis strains is considering how each strain influences your mood and sensations.

For instance, if you acquire a strain that imparts an invigorating and mentally uplifting high but induces a slight sense of anxiety, you could mitigate any adverse effects by combining it with a more soothing strain.


Conversely, come across a strain that delivers a relaxing, full-body effect but tends to induce couch lock. Mix it with a strain that offers a gentle, uplifting sensation to counteract the couch lock effect.


A helpful guideline to remember is to refrain from mixing strains at opposite ends of the spectrum. A highly energizing and euphoric strain may not harmonize well with one that provides intense, full-bodied relaxation.


Before embarking on your strain mixing journey, consider this vital question: Are you aiming for an indica-like relaxation without an instant knockout? If so, consider pairing an Indica strain with a hybrid that can elevate your high into an enjoyable yet tranquil experience.


Lastly, exercise caution when combining two potent strains. Mixing two strains introduces you to an entirely novel experience, one that has the potential to yield a new, albeit unfavorable, high—the kind where you feel both hyperactive and simultaneously inclined to sleep for extended periods.


Begin with a measured approach, and don’t hesitate to seek guidance at your dispensary. Ultimately, the goal is to have an enjoyable time and explore new horizons.





Source link

Continue Reading

Cannabis News

More New York Cannabis Program Litigation: First Amendment Challenge to Third-Party Website Rules




On September 18, 2023, a new lawsuit was filed by, inter alia, Leafly Holdings, Inc. (“Leafly”) against the New York State Office of Cannabis Management (“OCM”) and New York State Cannabis Control Board (the “Cannabis Control Board”).

The lawsuit

This legal proceeding involves a First Amendment and other challenges to certain regulations adopted by the Cannabis Control Board. The regulations, known as Resolution 2023-32, introduce new rules under Parts 123 and 124 of the Revised Adult-Use Cannabis Regulations, which significantly restrict the ability of New York dispensaries and consumers to use third-party websites that aggregate information about cannabis products. The petitioners, including Leafly, Stage One Cannabis, LLC (“Stage One Dispensary”), and Rosanna St. John, are seeking to have these regulations invalidated on the grounds that they are arbitrary, capricious, and in violation of both the United States Constitution and the New York Constitution. They are also requesting a temporary halt to the enforcement of these regulations until the legal proceedings are resolved.

The specific provisions being challenged are:

  1. The Third-Party Marketing Ban (9 N.Y.C.R.R. §§ 123.10(g)(21) and 124.5(a)), which restricts certain types of marketing by third-party websites.
  2. The Pricing Ban (9 N.Y.C.R.R. § 124.1(b)(5)(ii)), which imposes limitations on pricing information.
  3. The Third-Party Order Ban (9 N.Y.C.R.R. § 123.10(g)(23)), which restricts the ability to place orders through third-party websites.
  4. The Third-Party All-Licensee Listing Mandate (9 N.Y.C.R.R. § 124.1(b)(2)), which requires third-party websites to list all cannabis licensees.
  5. The Third-Party Distributor Listing Mandate (9 N.Y.C.R.R. § 124.1(c)(1)-(2)), which mandates the listing of third-party distributors.

The arguments

The petitioners argue that the Third-Party Marketing Ban and the Pricing Ban infringe upon free speech rights protected by the First Amendment of the U.S. Constitution and Article I, § 8 of the New York Constitution by limiting lawful commercial speech. They also claim that all the challenged regulations are arbitrary and capricious because they either conflict with New York’s Cannabis Law, lack a rational basis, or exceed the authority of the Cannabis Control Board.

What the plaintiffs want

Furthermore, the petitioners are requesting a temporary stay on the enforcement of these regulations, asserting that they are likely to succeed in their legal challenge and that they are facing irreparable harm due to the violation of their constitutional rights and potential business losses. They argue that maintaining the status quo is in the best interest of justice, and they urge the court to invalidate these regulations on the grounds of being arbitrary, capricious, irrational, and unconstitutional.


This First Amendment challenge is just the latest litigation, unfortunately, in a program that has seen a number of misfires and delays. We will continue to monitor this lawsuit, while awaiting answers on fundamental issues that the Cannabis Control Board has inexplicably failed to address. Stay tuned to our New York coverage for more.

Source link

Continue Reading


Copyright © 2021 The Art of MaryJane Media